Vismodegib

Back to search

Molecule Structure

Scientific Name

Vismodegib

Description of the Drug

Vismodegib is a hedgehog pathway inhibitor used to treat patients with locally advanced or metastatic basal cell carcinoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB08828

Brand Name(s)

Erivedge

Company Owner(s)

Genentech Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Smoothened homolog SINGLE PROTEIN INHIBITOR CHEMBL5971

Unichem Links

SureChEMBL SCHEMBL302587
DrugBank DB08828
PubChem: Thomson Pharma 49701104
PubChem 24776445
Mcule MCULE-6680076172
LINCS LSM-45691
Nikkaji J2.711.865H
PDBe VIS
BindingDB 50249522
EPA CompTox Dashboard DTXSID40236689
DrugCentral 4227
ChemicalBook CB52500590
Guide to Pharmacology 6975
GSRS e26230eb-ea99-4f87-be03-4480d97fa722
rxnorm ERIVEDGE VISMODEGIB
PubChem: Drugs of the Future 99431642
ChEBI 66903
ZINC ZINC000040899447